Shenzhen-based biomedical company founded in 2007 that develops in vitro diagnostic reagents, including nucleic acid detection kits.
Shenzhen Kangmei biological Polytron Technologies Inc., established in 2007 and headquartered in Shenzhen, China, researches, develops, produces and sells biomedical products, mainly in vitro diagnostic reagents. Its products include nucleic acid detection kits for Neisseria gonorrhoeae, Chlamydia trachomatis and Urea plasma urealyticum, used in clinical diagnostics. It has branches in Beijing and Wuhan. Revenue comes from diagnostic reagents and instruments. The company is at Series C stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in